Blog | HemaCare

Cancer Drug Targeting T cells: The CTLA-4 Checkpoint Inhibitor

Mar 23, 2015 1:00:53 PM / by Daisy posted in cancer drug, cancer immunotherapy, checkpoint inhibitors, CTLA-4, PD-1, research

0 Comments

Immune checkpoints modulate either the activation or downplay of T cells but can be manipulated by cancer cells. We can strike back with newer drugs.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts